Molecular structure of 3-Hydroxy-2-methylbutanoic Acid, CAS Number: 473-86-9
3-Hydroxy-2-methylbutanoic Acid (CAS 473-86-9)
See product citations (3)
Alternate Names:
2-Methyl-3-hydroxybutyric Acid; 3-Hydroxy-2-methylbutyric Acid; Nilic Acid
Application:
3-Hydroxy-2-methylbutanoic Acid is a urinary metabolite
CAS Number:
473-86-9
Molecular Weight:
118.13
Molecular Formula:
C5H10O3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
3-Hydroxy-2-methylbutanoic Acid is utilized as a building block for the synthesis of more complex molecules. Its unique structure allows for the creation of stereoisomers, making it valuable for studies concerning stereoselectivity and reaction mechanisms. 3-Hydroxy-2-methylbutanoic Acid also serves as a reference compound in analytical methods such as chromatography, aiding in the separation and quantification of substances with similar properties. Additionally, its involvement in certain metabolic pathways makes it an important substance for metabolic studies and research into biochemical processes.
3-Hydroxy-2-methylbutanoic Acid (CAS 473-86-9) References
- Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions. | Moudgil, A., et al. 2005. Pediatr Nephrol. 20: 1376-81. PMID: 15977023
- Mycophenolate mofetil therapy for inflammatory eye disease. | Thorne, JE., et al. 2005. Ophthalmology. 112: 1472-7. PMID: 16061096
- Mycophenolate mofetil therapy for sarcoidosis-associated uveitis. | Bhat, P., et al. 2009. Ocul Immunol Inflamm. 17: 185-90. PMID: 19585361
- Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review. | Smith, MR. and Cooper, SC. 2014. J Crohns Colitis. 8: 890-7. PMID: 24507162
- Mycophenolate mofetil therapy for severe immune thrombocytopenia. | Taylor, A., et al. 2015. Br J Haematol. 171: 625-30. PMID: 26250874
- Mycophenolate Mofetil Therapy in Refractory Inflammatory Eye Disease. | Cuchacovich, M., et al. 2016. J Ocul Pharmacol Ther. 32: 55-61. PMID: 26562247
- Mycophenolate mofetil therapy for two cases of antiphospholipid antibody-associated chorea. | Yokoyama, K., et al. 2018. Mod Rheumatol. 28: 709-711. PMID: 26708652
- The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy. | Filler, G., et al. 2017. Pediatr Nephrol. 32: 21-29. PMID: 26921212
- Laboratory monitoring requirements during mycophenolate mofetil therapy for dermatologic conditions: A single-institution retrospective chart review. | Waldman, R. and Strober, BE. 2021. J Am Acad Dermatol. 85: 726-728. PMID: 30797844
- Effect of Mycophenolate Mofetil Therapy on Recurrence of Hepatocellular Carcinoma after Liver Transplantation: A Population-Based Cohort Study. | Tsai, YF., et al. 2021. J Clin Med. 10: PMID: 33917215
- Effect of corticosteroids combined with cyclophosphamide or mycophenolate mofetil therapy for IgA nephropathy with stage 3 or 4 chronic kidney disease: A retrospective cohort study. | Jia, Q., et al. 2022. Front Pharmacol. 13: 946165. PMID: 36120326
- Isolation and characterization of cytotoxic and antibacterial tetrasaccharide glycosides from Ipomoea stans. | Reynolds, WF., et al. 1995. J Nat Prod. 58: 1730-4. PMID: 8594150
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
3-Hydroxy-2-methylbutanoic Acid, 25 mg | sc-209603 | 25 mg | $316.00 | |||
3-Hydroxy-2-methylbutanoic Acid, 500 mg | sc-209603A | 500 mg | $826.00 |